Ben D. Kritz
ON Friday, the US Attorney’s Office for Northern California announced that the two principals behind the failed medical tech startup Theranos had been indicted on numerous wire fraud charges for bilking both investors and customers with the company’s supposedly “revolutionary” blood-testing device.